Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
cancer
4
×
life sciences
national blog main
biotech
boston top stories
clinical trials
avapritinib
blueprint medicines
national top stories
new york blog main
adeno-associated virus
andrew berens
cancer drugs
capmatinib
chemotherapy
cisplatin
codiak biosciences
cutaneous t-cell lymphoma
decibel therapeutics
deciphera pharmaceuticals
eli lilly
europe blog main
europe top stories
exosome
gastrointestinal stromal tumor
gastrointestinal stromal tumors
gene therapy
genentech
gist
gleevec
hearing loss
imatinib
indiana blog main
indiana top stories
jazz pharmaceuticals
joe burns
laurence reid
life science
What
medicines
approval
blueprint
cancer
drug
fda
forms
adding
address
ago
aiming
announced
approves
balance
based
begin
biosciences
bio’s
brings
bubbles
build
carries
cells
certain
chasing
class
clinical
codiak
deadly
decibel
deciphera
designed
drugs
emerged
exosome
exosomes
filing
focus
formed
fund
Language
unset
4
×
Current search:
boston
×
unset
×
cancer
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug